1983
DOI: 10.1099/0022-1317-64-9-2021
|View full text |Cite
|
Sign up to set email alerts
|

Mechanism of Protection During the Early Phase of a Generalized Viral Infection. I. Contribution of Phagocytes to Protection against Ectromelia Virus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0

Year Published

1986
1986
2014
2014

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 23 publications
(20 citation statements)
references
References 15 publications
1
19
0
Order By: Relevance
“…It has already been shown that the pretreatment of suckling mice with syngeneic adult macrophages before MCMV infection resulted in a significant decrease of the percent mortality compared with mice without cell transfer, and that pretreatment of mice with silica before MCMV infection resulted in greater mortality as compared to control mice (31). Macrophages can be depleted by the administration of silica (12,25,31), asbestos (12), carrageenan (32,38), and by a number of other treatments (34,38). However, none of these treatments results in the complete depletion of all macrophage subpopulations.…”
Section: Discussionmentioning
confidence: 99%
“…It has already been shown that the pretreatment of suckling mice with syngeneic adult macrophages before MCMV infection resulted in a significant decrease of the percent mortality compared with mice without cell transfer, and that pretreatment of mice with silica before MCMV infection resulted in greater mortality as compared to control mice (31). Macrophages can be depleted by the administration of silica (12,25,31), asbestos (12), carrageenan (32,38), and by a number of other treatments (34,38). However, none of these treatments results in the complete depletion of all macrophage subpopulations.…”
Section: Discussionmentioning
confidence: 99%
“…Carrageenan type II (Sigma) was dissolved in distilled water (10 mg/ml). Mice were injected intraperitoneally with carrageenan (200 mg/kg) to deplete mainly tissue macrophages in the liver and spleen, and blood monocytes (Catanzaro et at., 1971) as well as to increase PMN in the blood (Tatsukawa et al, 1979;Tsuru et al, 1983). To impair the function of alveolar macrophages, 50 gl of carrageenan (1 mg/ml) diluted in MEM was administered intranasally to mice (2 mg/kg) 2 days before the virus infection.…”
Section: Methodsmentioning
confidence: 99%
“…In contrast, little is known of the protective role of such phagocytes in the early phase of generalized virus infection prior to the development of specific immune responses. In a previous study, we noted a significant role of macrophages in early protection against ectromelia virus infection in mice (Tsuru et al, 1983). However, there has been little study of the potential contribution of PMN to protection in the early phase against virus infections in vivo.…”
Section: Introductionmentioning
confidence: 99%
“…This is because ECTV is naturally mouse adapted and expresses virulence factors, such as the IFN-␥ binding protein (28), that have greater affinity for the mouse than the VACV equivalents. It has been established that macrophages (20,43), NK cells (17), and CD8…”
Section: Genetic Resistance To Clinical Mousepox (Ectromelia Virus) Vmentioning
confidence: 99%